GCT Delivery | Perfecting the Technology
Thursday, May 20, 2021
1:40 PM – 2:05 PM
Gene delivery uses physical, chemical, or viral means to introduce genetic material into cells. As more genetically modified therapies move closer to the market, challenges involving safety, efficacy, and manufacturing have emerged. Optimizing lipidic and polymer nanoparticles and exosomal delivery is a short-term priority. This panel will examine how the short-term and long-term challenges are being tackled particularly for non-viral delivery modalities.
- Moderator:
-
- Natalie Artzi, PhD
-
- Assistant Professor, BWH
- Speakers:
-
- Geoff McDonough, MD
-
- CEO, Generation Bio
- Sonya Montgomery
-
- CMO, Evox Therapeutics
- Laura Sepp-Lorenzino, PhD
-
- Chief Scientific Officer, Executive Vice President, Intellia Therapeutics
- Doug Williams, PhD
-
- CEO, Codiak BioSciences
-
Q&A
02:10 PM – 02:25 PM